Invuity has reintroduced its PhotonBlade to the market, more than three months after it recalled the minimally invasive surgery light due to “unintended energy discharge” during procedures. The new and improved PhotonBlade includes what Invuity officials describe as enhancements to improve energy delivery and provide optimized illumination performance. The new PhotonBlade will ship to customers […]
Abiomed touts survival rates for its Impella right-side heart pump | TCT 2014 Roundup
Abiomed (NSDQ:ABMD) got some Wall Street love today after releasing positive outcomes from a clinical trial of its minimally invasive Impella Right Percutaneous heart pump.
Researchers reported an overall 73% 30-day survival rate in the small study of patients with right ventricular heart failure, according to data Abiomed released during the Transcatheter Cardiovascular Therapeutics conference in Washington D.C.
Harpoon Medical raises $3.8M for mitral valve device
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.
Israel-based Keystone Heart raises $14M for cerebral protection
Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
J&J shelves surgical morcellators following FDA cancer warning
FDA warns that breaking up uterine tissue for removal may spread cancer
FDA officials issued a formal warning today asking doctors to avoid a certain method for removing uterine tissue out of concern that it may cause stealthy cancers to spread beyond the uterus.
Intuitive Surgical hopes to conquer more complex surgeries with new da Vinci Xi
Israel’s Medigus lands FDA win for new MUSE acid reflux treatment
Edwards lands E.U. approval for transcatheter mitral or aortic valve-in-valve
Benvenue Medical wins 510(k) clearance for spinal device
Benvenue Medical secured 510(k) clearance from the FDA, for its Kiva VCF system to treat vertebral compression fractures.
Santa Clara, Calif.-based Benvenue Medical designs and manufactures minimally invasive spinal repair devices. The Kiva VCF is the company’s marquee product, able to treat vertebral compression fractures due to osteoporosis. The device deploys the Kiva coil and Kiva implant.
Neovasc soars on 1st-in-human implant of Tiara transcatheter mitral valve
- 1
- 2
- 3
- 4
- Next Page »
